Ameritas Investment Partners, Inc. Aligos Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.04 - $2.14 $1,529 - $3,147	-1,471 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$20.3 - $33.6 $12,687 - $21,000	625 Added 73.88%	1,471 $30,000
Q4 2020 Feb 12, 2021	BUY	$13.2 - $32.74 $11,167 - $27,698	846 New	846 $23,000

240K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $751M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.